ClearPoint Neuro (CLPT) Total Debt Growth (1y) (2012 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.57% |
| Sep 30, 2023 | 0.57% |
| Jun 30, 2023 | 0.57% |
| Mar 31, 2023 | 0.57% |
| Dec 31, 2022 | 0.56% |
| Sep 30, 2022 | -43.91% |
| Jun 30, 2022 | -43.64% |
| Mar 31, 2022 | -59.82% |
| Dec 31, 2021 | -60.65% |
| Sep 30, 2021 | 1,865.74% |
| Jun 30, 2021 | 1,853.57% |
| Mar 31, 2021 | 40.09% |
| Dec 31, 2020 | 1,105.98% |
| Sep 30, 2020 | -52.02% |
| Jun 30, 2020 | -52.06% |
| Mar 31, 2020 | 799.80% |
| Dec 31, 2019 | 6.86% |
| Sep 30, 2019 | -3.49% |
| Jun 30, 2019 | 43.94% |
| Mar 31, 2019 | 63.47% |
| Dec 31, 2018 | -1.55% |
| Dec 31, 2017 | -7.55% |
| Dec 31, 2016 | 89.77% |
| Sep 30, 2016 | 49.82% |
| Jun 30, 2016 | -31.46% |
| Mar 31, 2016 | -32.04% |
| Dec 31, 2015 | -81.93% |
| Sep 30, 2015 | -77.12% |
| Jun 30, 2015 | -28.77% |
| Mar 31, 2015 | -1.50% |
| Dec 31, 2014 | -18.21% |
| Sep 30, 2014 | 65.24% |
| Jun 30, 2014 | -4.81% |
| Mar 31, 2014 | -5.41% |
| Dec 31, 2013 | 84.10% |
| Sep 30, 2013 | 12.51% |
| Jun 30, 2013 | 2,936.55% |
| Mar 31, 2013 | 3,813.37% |
| Dec 31, 2012 | 2,024.55% |